Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dave Gore's Trades That Make Sense -- Ignore unavailable to you. Want to Upgrade?

To: re3 who wrote (11522)	8/22/2002 12:47:02 PM
From: The Vet	Respond to of 16631

< do you have a sell target on GMXX ? > This is an early stage biotech with a small float and it has been shorted heavily by the MMs. The shorts are naked and they will do everything in their power to manipulate it back down. However they have a very exciting technology in a unique cure for very nasty cancers and if they have any success in human trials this stock will fly. Animal tests have been very promising. As far as a target goes I will probably trade some over $10 but I am keeping a core position in this for a couple of years... If this short squeeze continues, I expect my core position will soon have a cost base of zero; but I will be happy to hold at the present price regardless

To: re3 who wrote (11522)	8/22/2002 2:40:47 PM
From: yard_man	Read Replies (1) \| Respond to of 16631

interesting >>announced today that it is taking increased measures to ensure that trading in the shares of the Company occurs in a fair and appropriate manner. Shareholders have complained to the Company that they cannot obtain their share certificates when they purchase GeneMax shares from their broker. The Company's actions come in response to evidence that proves that more shares have been purchased than what should be possible due to the lack of actual delivery of shares sold in those transactions. The result is an over supply of stock sales that can negatively affect Company share prices. The Company is exiting the Depository Trust and Canadian Depository systems immediately in order to ensure its program of certificated ownership is enacted, and is taking other steps to ensure the authenticity of the Company's share trading system. The Company will monitor on an ongoing basis possible manipulations to its issued capital in conjunction with regulatory authorities. The process is intended to ensure that shareholder value is maintained according to a fair trading process. <<